FSTL1 and Hepatic fibrosis: Then we examined whether Fstl1 neutralizing antibody (22B6 mAb) would ameliorate CCl4-induced liver fibrosis in vivo, we treated Babl/c mice with 22B6 mAb or IgG1 along with CCl4 treatment.